Fig. 1: Serology testing protocol for evaluation of SARS-CoV-2 seropositivity in a large-scale population. | Nature Communications

Fig. 1: Serology testing protocol for evaluation of SARS-CoV-2 seropositivity in a large-scale population.

From: Standardization of ELISA protocols for serosurveys of the SARS-CoV-2 pandemic using clinical and at-home blood sampling

Fig. 1

Utilizing both venipuncture-derived fresh blood and dried blood spots, we have standardized a dual-antigen ELISA platform for highly specific (IgG = 100%, 95% confidence interval = 98.5–100) detection of SARS-CoV-2 antibodies for application in precise, large-scale serosurvey efforts.

Back to article page